{"id":7454,"date":"2022-10-11T12:15:26","date_gmt":"2022-10-11T10:15:26","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR_Seventure-Partners-x-Clinical-Microbiomics_Release-11.10.22.pdf"},"modified":"2022-10-11T12:15:26","modified_gmt":"2022-10-11T10:15:26","slug":"pr_seventure-partners-x-clinical-microbiomics_release-11-10-22","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/clinical-microbiomics-set-to-accelerate-its-expansion-with-eur-10-million-investment-from-health-for-life-capital-ii-managed-by-seventure-partners\/pr_seventure-partners-x-clinical-microbiomics_release-11-10-22\/","title":{"rendered":"PR_Seventure Partners x Clinical Microbiomics_Release 11.10.22"},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-7454","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n